Jump to navigation
I am personally committed to making the IASLC as effective as possible at accomplishing its mission of reducing the impact of thoracic cancers worldwide.
A major role of the IASLC is to integrate and facilitate multidisciplinary and international collaborations in pursuit of our mission to “conquer thoracic cancers worldwide.”
The management of patients thoracic cancers presents both unique opportunities as well as challenges.
As the new year begins, the IASLC is reviewing its operations, meetings and publications to best serve its members.
The IASLC 17th World Conference on Lung Cancer (WCLC) recently concluded in Vienna, Austria, and by all accounts it was a resounding success.
With the recent presentation of the data from Keynote-024, and the recent approval of pembrolizumab for high PD-L1 expressing tumors, the landscape of lung cancer oncology will change dramatically and for the better.
Join the only international association solely dedicated to lung cancer research and treatment.
The IASLC’s premier journal, emphasizing a multidisciplinary approach including original research (clinical trials and translational or basic research), reviews and opinion pieces.
Visit theWCLC Virtual Library